Typhoid
We’re long past due to eradicate typhoid, a bacterial infection that sickens up to 20 million people every year.
Climate change, urbanization and drug resistance are creating optimal conditions for typhoid to spread. Tracking the disease can be challenging, especially for rural and under-resourced communities. The primary diagnostic test — a blood culture — requires special laboratory facilities to process.
But there is hope. For the first time, infants and young children, who experience the greatest impact of typhoid, are eligible for typhoid vaccines.
We work to ensure that countries where typhoid is common have the data they need to make strategic decisions about introducing the new typhoid conjugate vaccines. We also partner with scientists and health workers to advance a holistic approach that includes vaccines and WASH (water, sanitation and hygiene) strategies.
We make vaccines more accessible, enable innovation and expand immunization across the globe.